The largest database of trusted experimental protocols

4 protocols using radioimmunoprecipitation assay buffer

1

Quantification of DLC Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
A-549 cells transfected with the empty vector pcDNA3.1, pcDNA3.1-DLC1, pcDNA3.1-DLC2 or pcDNA3.1-DLC3 were lysed using radioimmunoprecipitation assay buffer (CWBiotech) for protein extraction. Total protein was quantified using a bicinchoninic acid assay and 20 µg protein/lane was separated by a 10% SDS-PAGE. The separated proteins were subsequently transferred onto a PVDF membrane and blocked in 5% non-fat milk at 25°C for 1 h. The membranes were incubated with primary antibodies against DLC1 (cat. no. ab126257; 1:500; Abcam), DLC2 (cat. no. ab126489; 1:500; Abcam), DLC3 (cat. no. 13899-1-AP; 1:400; ProteinTech Group, Inc.) and GAPDH (cat. no. 10494-1-AP; 1:5,000; ProteinTech Group, Inc.) overnight at 4°C. Following the primary incubation, membranes were incubated with horseradish peroxidase-labeled secondary antibodies (cat. no. A00001-2; 1:5,000; ProteinTech Group, Inc.) for 1 h at room temperature. Protein bands were visualized using the enhanced chemiluminescence system. Protein expression was density-quantified using ImageJ software (version 1.49; National Institutes of Health) with GAPDH as the loading control.
+ Open protocol
+ Expand
2

Western Blot Analysis of TXNIP Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cell protein was extracted with radioimmunoprecipitation assay buffer (CWBIO, Beijing, China) and the protein concentration was detected by the BCA kit (CWBIO). Proteins were then separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. These membranes were blocked with 5% skimmed milk powder for 1 hour, washed several times with Tris-buffered saline and Tween 20, then incubated with primary antibodies against TXNIP (dilution 1:1000; Cell Signaling Technology Inc., Danvers, MA, USA) and β-actin (dilution 1:1000; Cell Signaling Technology Inc.) at 4°C overnight. They were then incubated with secondary antibodies conjugated to horseradish peroxidase (dilution 1:5000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at room temperature for 2 hours, and protein bands were visualized with ECL reagent (GE Healthcare, Chicago, IL, USA) and imaged by the typhoon scanner (GE Healthcare). β-actin was used as an internal reference.
+ Open protocol
+ Expand
3

Protein Expression Analysis Using Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein isolation was done using radioimmunoprecipitation assay buffer (CWBio, Beijing, China), and protein concentration was detected using a bicinchoninic acid protein assay kit (Tiangen, Beijing, China). Then, an equal amount of proteins was split by sodium dodecyl sulfonate-polyacrylamide gel (Solarbio) electrophoresis and blotted onto polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). The membranes were blocked using 5% nonfat milk for 1 h at indoor temperature. Next, the membranes were immunoblotted with primary antibodies against GAPDH (ab181602; Abcam), total p65 (t-p65; ab16502; Abcam), phosphorylated p65 (p-p65; ab86299; Abcam), B-cell lymphoma-2 (Bcl-2, ab196495; Abcam), BCL2-associated X (Bax, ab180733; Abcam), cleaved-caspase 3 (C-caspase 3, ab49822; Abcam), or total-caspase 3 (t-caspase 3, ab90437; Abcam) overnight at 4°C and then incubated with corresponding secondary antibody (ab6789; Abcam) for 1.5 h at indoor temperature. Finally, the protein bands were exposed through an enhanced chemiluminescence reagent (Vazyme) and analyzed by software Image J.
+ Open protocol
+ Expand
4

Melanoma Cell Line Establishment and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human melanoma A375 and A2058 cells used in this study were purchased from Fenghui Biotechnologies Inc. (Changsha, Hunan, China). Protocols for the establishment and culture of vemurafenib-resistant A375R cells were reported previously [11] . A375, A375R and A2058 cells were cultured in Dulbecco's modified Eagle's medium (High Glucose) (Gibco, Rockford, IL, USA) supplemented with 10% foetal bovine serum (Gibco, USA) and 1% penicillin/streptomycin (Thermo Fisher Scientific, MA, USA). Human umbilical cord mesenchymal stem cells (MSCs) were a kind gift from Professor Jingqiu Cheng (West China Hospital, Sichuan University, China) [12] . MSCs were cultured in Dulbecco's modified Eagle's medium (Low Glucose) (Gibco, Rockford, IL, USA) supplemented with 10% foetal bovine serum. Vemurafenib was purchased from Shanghai Yuanye Bio-Technology Co. (Shanghai, China). Dabrafenib was purchased from DC Chemicals (Shanghai, China). Cobimetinib and trametinib were purchased from CSNpharm (Chicago, IL, USA). Morusin was purchased from Weikeqi Biotechnology Co. (Chengdu, Sichuan, China). Radioimmunoprecipitation assay buffer and phosphatase inhibitors were obtained from CWBIO (Beijing, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!